Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stannous Fluoride Dentifrice for Gingivitis and Plaque
NCT03936569Phase 4Completed
- Sponsor
- Procter & Gamble
- Start
- Oct 2018
- Primary completion
- Jan 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of stannous fluoride in gingivitis (2 arms), sponsored by Procter & Gamble. Primary endpoint: Löe-Silness Gingivitis Evaluation at 3 Months. Started Oct 2018; status: completed.
02
Drugs
stannous fluoride
03
Conditions
gingivitis
Beyond the preview
Go deeper on NCT03936569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03936569.